A breakthrough in imaging technology promises to transform our understanding of the inner workings of living cells, and provide insights into a wide range of diseases.

CD8 T cells lacking Tet1/3 preferentially differentiate into short-lived effector and effector memory cells following acute ...

A team led by Professor Kazuhiro Maeshima of the National Institute of Genetics (ROIS) and SOKENDAI in Japan has developed a ...

Results of a phase I/II clinical trial of CALEC, limbal epithelial cell grafts generated by an innovative and rigorously standardized manufacturing protocol, showing safety and feasibility for ...

In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against other top stocks everyone is talking about these days. Major AI stocks are wavering as investors ...

Bill sets fines of up to $38 million or 7% of turnover on companies Aligned with EU's AI Act, it targets transparency and bans harmful practices New AI supervisory agency AESIA to enforce most ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond ...

In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against the other stocks. Some of the major U.S. indexes began recovering on Wednesday, following the ...

The FDA said it would delay implementation of a rule making it harder for many food companies to label their products as “healthy.” The effective date, previously Feb. 25, has been pushed to April 28 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Department of Cell and Molecular Biology at Karolinska Institutet is a nationally leading academic research center of high international standard where science comes first and foremost. CMB ...